innohep
Innohep (Tinzaparin Sodium) is a medication used to treat Pulmonary Embolism, Thromboembolism, Venous Thrombosis.
Tinzaparin Sodium · by Leo Pharma As
Key facts
- Active ingredient
- Tinzaparin Sodium
- Form
- Injectable
- Strength
- Tinzaparin Sodium 20,000 IU/ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- pulmonary embolism, thromboembolism, venous thrombosis
- Manufacturer
- Leo Pharma As
- FDA application
- NDA020484
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Innohep treat?
- Innohep (Tinzaparin Sodium) may be used to treat pulmonary embolism, thromboembolism, venous thrombosis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Innohep?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Innohep. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Innohep?
- Innohep is marketed by Leo Pharma As. You can see Leo Pharma As's full profile, rating, and other products on pharmaranks.
- Is Innohep a brand-name or generic drug?
- Innohep is a brand-name product with the active ingredient Tinzaparin Sodium.
- Is Innohep available over the counter?
- No. Innohep is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Innohep come in?
- Innohep is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Innohep FDA-registered?
- Innohep is on record with the U.S. FDA under application number NDA020484. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about TINZAPARIN SODIUM
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 1,109 reports naming TINZAPARIN SODIUM — the active ingredient in Innohep, and the FDA flagged 99% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- dyspnoea63 reports
- diarrhoea56 reports
- acute kidney injury55 reports
- maternal exposure during pregnancy41 reports
- renal failure40 reports
- pyrexia39 reports
- general physical health deterioration38 reports
- pancytopenia38 reports
Read these as a signal, not a rate. A report does not mean TINZAPARIN SODIUM caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
pradaxa
Dabigatran Etexilate Mesylate
xarelto
Rivaroxaban
activase
Alteplase
cathflo activase
Alteplase
lovenox
Enoxaparin Sodium
heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin Sodium
Compare Innohep head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
innohep
New